Comparative Effectiveness of [18F]-Fluorocholine PET-CT and Pelvic MRI With Diffusion-Weighted Imaging for Staging in Patients With High-Risk Prostate Cancer

被引:57
|
作者
Pinaquy, Jean-Baptiste [1 ]
De Clermont-Galleran, Henri [1 ,2 ]
Pasticier, Gilles [3 ]
Rigou, Gerald [4 ]
Alberti, Nicolas [4 ]
Hindie, Elif [1 ,2 ]
Mokrane, Yacoub [5 ]
Fernandez, Philippe [1 ,2 ]
机构
[1] Hop Pellegrin, Dept Nucl Med, F-33076 Bordeaux, France
[2] Univ Bordeaux, INCIA, UMR CNRS 5287, Bordeaux, France
[3] Hop Pellegrin, Dept Urol, F-33076 Bordeaux, France
[4] Hop Pellegrin, Dept Radiol, F-33076 Bordeaux, France
[5] Hop Pellegrin, Dept Pathol, F-33076 Bordeaux, France
来源
PROSTATE | 2015年 / 75卷 / 03期
关键词
F-18]-fluorocholine; DWI; MRI; prostate cancer; staging; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; LYMPH-NODES; RADICAL PROSTATECTOMY; LOCALIZATION; INTERMEDIATE; NOMOGRAM; DISEASE;
D O I
10.1002/pros.22921
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Accurate staging is important before surgical decision in patients with high-risk prostate cancer (PCa). The purpose of this study was to prospectively compare the diagnostic performance of F-18-FCholine and MRI with diffusion weighted imaging (DWIMRI) for local and regional lymph node (LN) staging before radical prostatectomy (RP) with extended pelvic lymphadenectomy (PLND). METHODS. We identified 47 patients who underwent F-18-FCholine and DWIMRI followed by surgical treatment (either prostatectomy or LN dissection or an association of prostatectomy and LN dissection) between May 2010 and December 2012 at Bordeaux University Hospital. These patients were part of a prospective study (EudraCT number 2009-014839-21) evaluating the interest of F-18-FCholine in staging of high-risk PCa. Diagnostic performances were retrospectively determined for each of F-18-FCholine and DWIMRI considering LN invasion, each of prostate sextants, capsular invasion and extension to seminal vesicles. F-18-FCholine and MR findings were correlated with histological findings. RESULTS. In a region-based LN analysis, the sensitivity and positive predictive value specificity were respectively, 56% and 98% for F-18-Choline, and 17% and 97% for DWIMRI. In a patient-based analysis the sensitivity and positive predictive value were respectively 78% and 94% for F-18-Choline and 33% and 84% for DWIMRI (P = 0.015). For tumor staging, DWIMRI showed better performances with a better specificity (69%) for sextants analysis and sensitivity to detect seminal vesicle invasion (73% vs. 36%). CONCLUSIONS. F-18-FCholine imaging appears to provide helpful additional information in the staging of high-risk PCa. It appears essential for predicting LN status due to its higher sensitivity and specificity for LN involvement. However, despite excellent performance, it cannot replace MRI that remains better for tumoral localization and local evaluation, especially for seminal vesicle invasion. PATIENT SUMMARY. This study highlights the interest of F-18-Choline in the staging of high risk prostate cancer in addition with DWI MRI, especially so in the evaluation of lymph node involvement due to its high sensitivity and excellent specificity. (C) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:323 / 331
页数:9
相关论文
共 50 条
  • [21] Comparison of 18F-sodium fluoride PET/CT, 18F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France
    Gauthe, Mathieu
    Zarca, Kevin
    Aveline, Cyrielle
    Lecouvet, Frederic
    Balogova, Sona
    Cussenot, Olivier
    Talbot, Jean-Noel
    Durand-Zaleski, Isabelle
    BMC MEDICAL IMAGING, 2020, 20 (01)
  • [22] Comparison of 18F-sodium fluoride PET/CT, 18F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France
    Mathieu Gauthé
    Kevin Zarca
    Cyrielle Aveline
    Frédéric Lecouvet
    Sona Balogova
    Olivier Cussenot
    Jean-Noël Talbot
    Isabelle Durand-Zaleski
    BMC Medical Imaging, 20
  • [23] Voxel-based correlation and combination of 18F-Fluorocholine PET and diffusion-weighted MRI in prostate cancer: a hybrid PET/MRI study
    Lee, Jungmin
    Choi, Hongyoon
    Paeng, Jin Chul
    Cheon, Gi Jeong
    Cho, Jeong Yeon
    Kwak, Cheol
    Lee, Dong Soo
    Chung, June-Key
    Kang, Keon Wook
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [24] 18F-Florastamin PET/CT for the initial staging of patients with high-risk prostate cancer
    Choi, W. H.
    Boo, S.
    Choi, Y.
    Kim, H.
    Lee, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S460 - S460
  • [25] PRIMARY METASTASIS STAGING USING 18F-PSMA-1007 PET-CT IN HIGH-RISK PROSTATE CANCER
    Anttinen, Mikael
    Ettala, Otto
    Malaspina, Simona
    Jambor, Ivan
    Sandell, Minna
    Kajander, Sami
    Rinta-Kiikka, Irina
    Schildt, Jukka
    Saukko, Ekaterina
    Rautio, Pentti
    Timonen, Kirsi L.
    Noponen, Tommi
    Saunavaara, Jani
    Loyttyniemi, Eliisa
    Taimen, Pekka
    Kemppainen, Jukka
    Dean, Peter B.
    Blanco, Roberto Sequeiros
    Aronen, Hannu J.
    Seppanen, Marko
    Bostrom, Peter J.
    JOURNAL OF UROLOGY, 2020, 203 : E952 - E952
  • [26] 18F-fluorocholine positron emission tomography-computed tomography (18F-FCH PET/CT) for staging of high-risk prostate cancer patients
    Gauvin, Simon
    Rompre-Brodeur, Alexis
    Chausse, Guillaume
    Anidjar, Maurice
    Bladou, Franck
    Probst, Stephan
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2019, 13 (04): : 84 - 91
  • [27] COMPARISON OF FLUCICLOVINE (18F) PET-CT AND MRI IN DETECTION OF RECURRENT PROSTATE CANCER
    Akin-Akintayo, Oladunni
    Tade, Funmilayo
    Mittal, Pardeep
    Moreno, Courtney
    Nieh, Peter
    Rossi, Peter
    Raghuveer, Halkar
    Fei, Baowei
    Goodman, Mark
    Schuster, David
    JOURNAL OF UROLOGY, 2017, 197 (04): : E222 - E223
  • [28] [18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer
    Mohsen Beheshti
    Reza Vali
    Werner Langsteger
    European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34 : 1316 - 1317
  • [29] Comparing PET-MRI and PET-CT with [18F]Fluorocholine for Detecting Parathyroid Lesions in Primary Hyperparathyroidism Patients
    Sanchez Rodriguez, I.
    Carrero-Vasquez, V.
    Suarez-Pinera, M.
    Moreno-Llorente, P.
    De Lama-Salvador, M.
    Cortes-Romera, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S364 - S365
  • [30] [18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer
    Beheshti, Mohsen
    Vali, Reza
    Langsteger, Werner
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (08) : 1316 - 1317